Upgrade to SI Premium - Free Trial

Astellas Pharma Inc (4503:JP) (ALPMY) PT Lowered to JPY2,450 at Goldman Sachs

April 15, 2026 8:15 AM
Goldman Sachs analyst Akinori Ueda lowered ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change Intl Ratings